ABM vs BIO · P/E 37, rev $4.53B vs rev $2.58B
ABM Industries Incorporated (ABM) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
ABM Industries Incorporated (ABM) is a specialty business services company listed on US.
BIO (BIO) common stock.
Latest reported ABM revenue for 2026-04-30 was $4.53B. Net income was $81.8M. ABM currently screens at market cap $2.85B and trailing P/E 36.6.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 287.0% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
ABM currently screens at market cap $2.85B and trailing P/E 36.6. BIO currently screens at market cap $0.
Not investment advice. Open the ABM and BIO stock pages for the full models.
Not investment advice.